Toxic epidermal necrolysis during camrelizumab treatment for esophageal squamous cell carcinoma. Peng Y, Yu Q, Zhang X, Zeng C, et al. Contact Dermatitis 2022;86:417-419.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peng Y, Yu Q, Zhang X, Zeng C, et al. Toxic epidermal necrolysis during camrelizumab treatment for esophageal squamous cell carcinoma. Contact Dermatitis 2022;86:417-419.
PMID: 34984690